Figure 1. Death and Disease Progression in Infants Receiving Early or Deferred Antiretroviral Therapy
In this clinical trial, investigators randomized infants with HIV and 6 to 12 weeks of age to receive early antiretroviral therapy versus deferred therapy (based on CD4-related criteria). As shown in this graph, the group in the deferred treatment group (orange bars) had a significantly higher rate of death and disease progression than those who received early treatment (blue bars).
Source: Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359:2233-44.
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
August 19th, 2026
August 19th, 2026